Bone Biologics Ownership 2024 | Who Owns Bone Biologics Now?
Institutional Ownership
0.06%
Insider Ownership
6.07%
Retail Ownership
93.87%
Institutional Holders
1.00
Bone Biologics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
Bone Biologics's largest institutional shareholder is UBS GROUP AG, holding 5.10% of the company's total share outstanding, currently valued at $41.12K. The top 10 institutional shareholders own together 8.69% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
The largest Bone Biologics shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 5.79K shares of Bone Biologics (BBLG), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Bone Biologics's largest institutional buyer is UBS GROUP AG. The company purchased 33.11K stocks of BBLG, valued at $41.12K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
As of Jun 30 2024, Bone Biologics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -37.00K shares of BBLG, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
Bone Biologics's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 17.52K shares, valued at $21.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Bone Biologics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -37.00K shares, valued at -, as of undefined.
Bone Biologics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 33,461 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 15,816 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 5,900 | - | - | Feb 29, 2024 |
Bone Biologics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 33.46K shares, compromising 0.00% of its total assets.
Bone Biologics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 1 | -75.00% |
31 Mar, 24 | 4 | 100.00% |
31 Dec, 23 | 2 | -75.00% |
30 Sep, 23 | 8 | 14.29% |
30 Jun, 23 | 7 | -12.50% |
31 Mar, 23 | 8 | -33.33% |
31 Dec, 22 | 12 | 500.00% |
30 Sep, 22 | 2 | -33.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | 3 | - |
As of 30 Jun 24, 1 institutions are holding Bone Biologics's shares, representing a decrease of -75.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 403 | -99.04% |
31 Mar, 24 | 41,854 | 3305.53% |
31 Dec, 23 | 1,229 | -99.63% |
30 Sep, 23 | 330,640 | -18.32% |
30 Jun, 23 | 404,792 | -83.83% |
31 Mar, 23 | 2,502,773 | 10.56% |
31 Dec, 22 | 2,263,720 | 5376.12% |
30 Sep, 22 | 41,338 | -12.60% |
30 Jun, 22 | 47,299 | -17.98% |
31 Mar, 22 | 57,666 | - |
Bone Biologics (BBLG) has 403.00 shares outstanding as of 30 Jun 24, down -99.04% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 0.06% | 0.15% |
31 Mar, 24 | 6.33% | 11968.43% |
31 Dec, 23 | 0.23% | 0.21% |
30 Sep, 23 | 10.55% | 6.32% |
30 Jun, 23 | 12.91% | 141.37% |
31 Mar, 23 | 3.02% | 40.44% |
31 Dec, 22 | 2.73% | 109741.88% |
30 Sep, 22 | 0.05% | 1530.65% |
30 Jun, 22 | 0.06% | 1178.45% |
31 Mar, 22 | 0.07% | - |
As of 30 Jun 24, Bone Biologics is held by 0.06% institutional shareholders, representing a 0.15% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | -66.67% |
31 Mar, 24 | 3 | - |
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 6 | 200.00% |
30 Jun, 23 | 2 | -50.00% |
31 Mar, 23 | 4 | -66.67% |
31 Dec, 22 | 12 | 1100.00% |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | -33.33% |
31 Mar, 22 | 3 | - |
1 institutional shareholders have increased their position in BBLG stock as of 30 Jun 24 compared to 3 in the previous quarter (a -66.67% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | - |
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 2 | - |
30 Sep, 23 | 2 | -60.00% |
30 Jun, 23 | 5 | 150.00% |
31 Mar, 23 | 2 | - |
31 Dec, 22 | - | - |
30 Sep, 22 | - | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
- institutional shareholders have reduced their position in BBLG stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 1 | -75.00% | 403 | -99.04% | 0.06% | 0.15% | 1 | -66.67% | - | - |
31 Mar, 24 | 4 | 100.00% | 41,854 | 3305.53% | 6.33% | 11968.43% | 3 | - | - | -100.00% |
31 Dec, 23 | 2 | -75.00% | 1,229 | -99.63% | 0.23% | 0.21% | - | -100.00% | 2 | - |
30 Sep, 23 | 8 | 14.29% | 330,640 | -18.32% | 10.55% | 6.32% | 6 | 200.00% | 2 | -60.00% |
30 Jun, 23 | 7 | -12.50% | 404,792 | -83.83% | 12.91% | 141.37% | 2 | -50.00% | 5 | 150.00% |
31 Mar, 23 | 8 | -33.33% | 2,502,773 | 10.56% | 3.02% | 40.44% | 4 | -66.67% | 2 | - |
31 Dec, 22 | 12 | 500.00% | 2,263,720 | 5376.12% | 2.73% | 109741.88% | 12 | 1100.00% | - | - |
30 Sep, 22 | 2 | -33.33% | 41,338 | -12.60% | 0.05% | 1530.65% | 1 | -50.00% | - | - |
30 Jun, 22 | 3 | - | 47,299 | -17.98% | 0.06% | 1178.45% | 2 | -33.33% | - | - |
31 Mar, 22 | 3 | - | 57,666 | - | 0.07% | - | 3 | - | - | - |
Bone Biologics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Bone Biologics's stock was made by Gagnon Robert E. on Jan 10 2024, selling - shares at - per share (valued at -). The last insider buy of BBLG was made by Walsh Deina H on Sep 14 2023, buying 8,000 shares at $0.64 per share (worth $5.12K).
Bone Biologics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 6 | 2 | 300.00% |
Q3 2023 | 16 | - | - |
Q1 2023 | 14 | 4 | 350.00% |
Q3 2022 | 6 | - | - |
Q1 2022 | 5 | - | - |
Q4 2021 | 6 | 4 | 150.00% |
Q1 2020 | 2 | - | - |
Q3 2019 | 4 | - | - |
Q2 2019 | 4 | - | - |
Q1 2019 | 3 | - | - |
Q4 2018 | 2 | - | - |
Q3 2018 | - | - | - |
Q1 2018 | 5 | - | - |
Q4 2017 | 1 | - | - |
Q3 2017 | 2 | 2 | 100.00% |
Q1 2017 | 2 | - | - |
Q3 2016 | 2 | 1 | 200.00% |
Q2 2016 | 2 | 1 | 200.00% |
Q1 2016 | 5 | - | - |
Q4 2015 | 22 | 9 | 244.44% |
6 total buy trades, and 2 total sell trades (buy/sell ratio of 3.00%) were made by Bone Biologics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q3 2023 | 10 | - | - |
Q1 2023 | - | - | - |
Q3 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q1 2020 | 2 | - | - |
Q3 2019 | 4 | - | - |
Q2 2019 | 4 | - | - |
Q1 2019 | 2 | - | - |
Q4 2018 | 2 | - | - |
Q3 2018 | - | - | - |
Q1 2018 | - | - | - |
Q4 2017 | - | - | - |
Q3 2017 | - | - | - |
Q1 2017 | - | - | - |
Q3 2016 | - | - | - |
Q2 2016 | - | - | - |
Q1 2016 | 1 | - | - |
Q4 2015 | - | 7 | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Bone Biologics's stocks.
Bone Biologics Peer Ownership
Ticker | Company |
---|---|
TLIS | Talis Biomedical Corporation |
RPID | Rapid Micro Biosystems, Inc. |
INVO | INVO Bioscience, Inc. |
TIVC | Tivic Health Systems, Inc. |
NUWE | Nuwellis, Inc. |
RSLS | ReShape Lifesciences Inc. |
BJDX | Bluejay Diagnostics, Inc. |
HSCS | Heart Test Laboratories, Inc. |
MOTS | Motus GI Holdings, Inc. |
SINT | Sintx Technologies, Inc. |
TNON | Tenon Medical, Inc. |
NAOV | NanoVibronix, Inc. |
VVOS | Vivos Therapeutics, Inc. |
BBLG Ownership FAQ
Who Owns Bone Biologics?
Bone Biologics is owned by institutional shareholders (0.06%), insiders (6.07%), and public (93.87%). The largest institutional shareholder of Bone Biologics is UBS GROUP AG (5.10% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Bone Biologics?
Bone Biologics's major institutional shareholders are UBS GROUP AG, HRT FINANCIAL LP, TOWER RESEARCH CAPITAL LLC (TRC), MFA WEALTH ADVISORS, LLC, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 8.69% of the company's share outstanding.
How many Bone Biologics shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Bone Biologics.
What percentage of Bone Biologics is owned by UBS GROUP AG?
UBS GROUP AG owns 33.71K shares of Bone Biologics, representing 5.10% of the company's total shares outstanding, valued at $41.12K (as of Jun 2024).
What percentage of Bone Biologics is owned by HRT FINANCIAL LP?
As of Jun 2024, HRT FINANCIAL LP holds 17.52K shares of Bone Biologics (BBLG), compromising 2.65% of the company, valued at $21K.
What percentage of Bone Biologics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Bone Biologics. The company owns 5.79K of the company's shares outstanding (worth $7.06K).